Doxorubicin may lead to myocardial damage, together with acute still left ventricular failure. The chance of cardiomyopathy is generally proportional for the cumulative publicity. Consist of prior doses of other anthracyclines or anthracenediones in calculations of overall cumulative dosage for doxorubicin. Cardiomyopathy might develop in the course of treatment method https://richardm766yjt8.blogs100.com/profile